13D/13G Filings - Avoro Capital Advisors LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
08:04 am
Purchase
2020-12-3113GGenocea Biosciences, Inc.
GNCA
Avoro Capital Advisors LLC33,613,444
9.990%
33,613,444increase
(New Position)
Filing
History
2021-02-12
08:03 am
Sale
2020-12-3113GIovance Biotherapeutics, Inc.
IOVA
Avoro Capital Advisors LLC7,500,000
5.100%
-1,326,039decrease
(-15.02%)
Filing
History
2021-02-12
08:01 am
Sale
2020-12-3113GConstellation Pharmaceuticals, Inc.
CNST
Avoro Capital Advisors LLC2,950,000
6.200%
-700,000decrease
(-19.18%)
Filing
History
2021-02-12
08:01 am
Purchase
2020-12-3113GFennec Pharmaceuticals Inc.
FENC
Avoro Capital Advisors LLC1,670,000
6.500%
564,001increase
(+50.99%)
Filing
History
2021-02-12
08:00 am
Purchase
2020-12-3113GAdverum Biotechnologies, Inc.
ADVM
Avoro Capital Advisors LLC800,000
8.200%
275,000increase
(+52.38%)
Filing
History
2021-02-12
08:00 am
Purchase
2020-12-3113GMirati Therapeutics, Inc.
MRTX
Avoro Capital Advisors LLC4,535,000
9.020%
621,565increase
(+15.88%)
Filing
History
2020-10-23
5:25 pm
Sale
2020-10-2313DIMMUNOMEDICS INC
IMMU
Avoro Capital Advisors LLC0
0.000%
-21,000,000decrease
(Position Closed)
Filing
History
2020-09-01
12:25 pm
Purchase
2020-08-3113GCymaBay Therapeutics, Inc.
CBAY
Avoro Capital Advisors LLC10,300,000
14.950%
4,800,000increase
(+87.27%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5